Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Clinical trial NCT03970044 · COMPLETED
Trial details
- NCT number
- NCT03970044
- Sponsor
- Consano Clinical Research, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-02
- Primary completion
- 2021-06-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.